Stefano Persiani

1.5k total citations
55 papers, 1.2k citations indexed

About

Stefano Persiani is a scholar working on Pharmacology, Oncology and Pharmacology. According to data from OpenAlex, Stefano Persiani has authored 55 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Pharmacology, 14 papers in Oncology and 14 papers in Pharmacology. Recurrent topics in Stefano Persiani's work include Inflammatory mediators and NSAID effects (11 papers), Osteoarthritis Treatment and Mechanisms (8 papers) and Pharmacogenetics and Drug Metabolism (6 papers). Stefano Persiani is often cited by papers focused on Inflammatory mediators and NSAID effects (11 papers), Osteoarthritis Treatment and Mechanisms (8 papers) and Pharmacogenetics and Drug Metabolism (6 papers). Stefano Persiani collaborates with scholars based in Italy, United States and France. Stefano Persiani's co-authors include Lucio C. Rovati, Aldo Roda, Marcello Locatelli, Giampaolo Giacovelli, E. Roda, M. Strolin Benedetti, Virginia B. Kraus, Yves Henrotin, Stefan Lohmander and Roberto Rotini and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Analytica Chimica Acta and Life Sciences.

In The Last Decade

Stefano Persiani

55 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stefano Persiani Italy 18 501 337 274 182 110 55 1.2k
A J Farrell United Kingdom 12 344 0.7× 152 0.5× 267 1.0× 153 0.8× 75 0.7× 13 1.2k
Shiro Nakaike Japan 23 219 0.4× 163 0.5× 414 1.5× 60 0.3× 90 0.8× 77 1.6k
Yuko Higashi Japan 18 69 0.1× 150 0.4× 339 1.2× 118 0.6× 130 1.2× 72 1.1k
G. Ronca Italy 25 287 0.6× 148 0.4× 785 2.9× 140 0.8× 74 0.7× 87 1.8k
Toshimitsu Yamada Japan 20 156 0.3× 139 0.4× 523 1.9× 110 0.6× 109 1.0× 52 1.6k
Song Jin China 20 129 0.3× 79 0.2× 646 2.4× 73 0.4× 110 1.0× 51 1.3k
Jing Luo China 22 191 0.4× 45 0.1× 642 2.3× 188 1.0× 242 2.2× 110 1.7k
Wissam H. Faour Lebanon 22 74 0.1× 275 0.8× 306 1.1× 95 0.5× 146 1.3× 59 1.1k
James Drake United States 14 154 0.3× 124 0.4× 339 1.2× 89 0.5× 125 1.1× 20 1.0k
Jeong Han Kang South Korea 26 47 0.1× 175 0.5× 781 2.9× 204 1.1× 163 1.5× 65 1.8k

Countries citing papers authored by Stefano Persiani

Since Specialization
Citations

This map shows the geographic impact of Stefano Persiani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stefano Persiani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stefano Persiani more than expected).

Fields of papers citing papers by Stefano Persiani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stefano Persiani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stefano Persiani. The network helps show where Stefano Persiani may publish in the future.

Co-authorship network of co-authors of Stefano Persiani

This figure shows the co-authorship network connecting the top 25 collaborators of Stefano Persiani. A scholar is included among the top collaborators of Stefano Persiani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stefano Persiani. Stefano Persiani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Caselli, Gianfranco, Albino Bonazzi, Marco Lanza, et al.. (2018). Pharmacological characterisation of CR6086, a potent prostaglandin E2 receptor 4 antagonist, as a new potential disease-modifying anti-rheumatic drug. Arthritis Research & Therapy. 20(1). 39–39. 32 indexed citations
2.
Persiani, Stefano, et al.. (2013). Silibinin hemisuccinate binding to proteins in plasma and blood cell/plasma partitioning in mouse, rat, dog and man in vitro. Drug metabolism and drug interactions. 28(2). 115–122. 3 indexed citations
3.
Biava, Mariangela, Claudio Battilocchio, Giovanna Poce, et al.. (2013). Enhancing the pharmacodynamic profile of a class of selective COX-2 inhibiting nitric oxide donors. Bioorganic & Medicinal Chemistry. 22(2). 772–786. 21 indexed citations
4.
5.
Kraus, Virginia B., Bruce K. Burnett, Javier Coindreau, et al.. (2011). Application of biomarkers in the development of drugs intended for the treatment of osteoarthritis. Osteoarthritis and Cartilage. 19(5). 515–542. 249 indexed citations
6.
Persiani, Stefano, Lucio C. Rovati, Elisabetta Pastorini, et al.. (2007). 412 PHARMACOKINETICS OF GLUCOSAMINE IN MAN AFTER ORAL ADMINISTRATION OF CRYSTALLINE GLUCOSAMINE SULFATE OR GLUCOSAMINE HYDROCHLORIDE ALONE OR IN COMBINATION WITH CHONDROITIN SULFATE. Osteoarthritis and Cartilage. 15. C223–C224. 3 indexed citations
7.
Persiani, Stefano, Roberto Rotini, Giovanni Trisolino, et al.. (2007). Synovial and plasma glucosamine concentrations in osteoarthritic patients following oral crystalline glucosamine sulphate at therapeutic dose. Osteoarthritis and Cartilage. 15(7). 764–772. 119 indexed citations
8.
Formelli, Franca, Elena Cavadini, Roberto Luksch, et al.. (2007). Pharmacokinetics of oral fenretinide in neuroblastoma patients: indications for optimal dose and dosing schedule also with respect to the active metabolite 4-oxo-fenretinide. Cancer Chemotherapy and Pharmacology. 62(4). 655–665. 23 indexed citations
9.
Roy, Partha Pratim, et al.. (2005). Effect of Multiple‐Dose Dexloxiglumide on the Pharmacokinetics of Oral Contraceptives in Healthy Women. The Journal of Clinical Pharmacology. 45(3). 329–336. 8 indexed citations
10.
Persiani, Stefano, E. Roda, Lucio C. Rovati, et al.. (2005). Glucosamine oral bioavailability and plasma pharmacokinetics after increasing doses of crystalline glucosamine sulfate in man. Osteoarthritis and Cartilage. 13(12). 1041–1049. 136 indexed citations
11.
Joshi, Hemant, et al.. (2003). Characterization of Dexloxiglumide in vitro Biopharmaceutical Properties and Active Transport. Journal of Pharmaceutical Sciences. 92(10). 1968–1980. 10 indexed citations
12.
Webber, Colin E., Angelika Roth, Stefano Persiani, et al.. (2003). Pharmacokinetics and metabolism of the cholecystokinin antagonist dexloxiglumide in male human subjects. Xenobiotica. 33(6). 625–641. 13 indexed citations
13.
Webber, Colin E., Clare Stokes, Stefano Persiani, et al.. (2003). Absorption, distribution, metabolism and excretion of the cholecystokinin-1 antagonist dexloxiglumide in the rat. European Journal of Drug Metabolism and Pharmacokinetics. 28(3). 201–212. 2 indexed citations
14.
Persiani, Stefano, Maria D’Amato, Francesco Makovec, et al.. (2001). Pharmacokinetics of andolast after administration of single escalating doses by inhalation in mild asthmatic patients. Biopharmaceutics & Drug Disposition. 22(2). 73–81. 14 indexed citations
15.
16.
Benedetti, M. Strolin, et al.. (1998). The oxidation of dopamine and epinine by the two forms of monoamine oxidase from rat liver. Journal of neural transmission. Supplementum. 52. 233–238. 2 indexed citations
17.
Dotto, Paolo Del, A. Colzi, M. Strolin Benedetti, et al.. (1997). Clinical and Pharmacokinetic Evaluation of L-dopa and Cabergoline Cotreatment in Parkinsonʼs Disease. Clinical Neuropharmacology. 20(5). 455–465. 17 indexed citations
18.
Persiani, Stefano, G. Sassolas, G. Piscitelli, et al.. (1994). Pharmacodynamics and Relative Bioavailability of Cabergoline Tablets vs Solution in Healthy Volunteers. Journal of Pharmaceutical Sciences. 83(10). 1421–1424. 21 indexed citations
19.
Persiani, Stefano, Aaron M. Yeung, Wei‐Chiang Shen, & Ann R. Kennedy. (1991). Polylysine conjugates of Bowman–Birk protease inhibitor as targeted anti-carcinogenic agents. Carcinogenesis. 12(6). 1149–1152. 23 indexed citations
20.
Persiani, Stefano & Wei‐Chiang Shen. (1989). Increase of poly(L-lysine) uptake but not fluid phase endocytosis in neuraminidase pretreated Madin-Darby canine kidney (MDCK) cells. Life Sciences. 45(26). 2605–2610. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A J Farrell Breakdown of academic impact, for papers by Shiro Nakaike Breakdown of academic impact, for papers by Yuko Higashi Breakdown of academic impact, for papers by G. Ronca Breakdown of academic impact, for papers by Toshimitsu Yamada Breakdown of academic impact, for papers by Song Jin Breakdown of academic impact, for papers by Jing Luo Breakdown of academic impact, for papers by Wissam H. Faour Breakdown of academic impact, for papers by James Drake Breakdown of academic impact, for papers by Jeong Han Kang
Rankless by CCL
2026